Business Wire
-
Babson Diagnostics Recognized For Achieving Highest Standards Of Quality And Patient Safety For Laboratory Medicine
1/24/2024
Babson Diagnostics, a science-first health care technology company, today announced its new, highly automated microsample laboratory has been awarded accreditation by the College of American Pathologists (CAP) based on the results of a recent on-site inspection.
-
Stevanato Group Launches EZ-Fill Kit And Laboratory Fill And Finish Service To Support Small Batch Drug Development And Commercialization
1/24/2024
Stevanato Group S.p.A. , a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, unveiled today two new offerings for efficient small batch pharmaceutical manufacturing: the EZ-fill Kit and the non-GMP laboratory fill and finish service at its Technology Excellence Centers (TEC).
-
Crown Bioscience's Global Oncology Research Facilities Achieve Prestigious ISO And CAP Accreditations
1/23/2024
Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, proudly announces that its global laboratory facilities have successfully passed a series of annual on-site ISO audits, achieving a flawless record with zero discrepancies.
-
Chemify Partners With Prepaire Labs To Apply Ground-Breaking Chemistry AI-Robotics To Radically Accelerate The Discovery Of Non-Addictive Opioids
1/18/2024
Chemify and Prepaire Labs today announced to expand their partnership with an additional program to tackle the ongoing Opioid crisis and develop a novel class of digitally discovered non-addictive Opioids as pain modulators, as well as drugs tackling Opioid addiction directly by combining Chemify's breakthrough programmable chemistry platform with Prepaire’s integrated novel open collaboration drug discovery platform.
-
Guardant Health To Present Data At ASCO GI Supporting Use Of Liquid Biopsy To Predict Colon Cancer Recurrence
1/17/2024
Guardant Health, Inc., a leading precision oncology company, will present interim data from the COSMOS study supporting the use of Guardant Reveal to predict disease recurrence in patients with early-stage colon cancer at the ASCO 2024 Gastrointestinal Cancers Symposium, January 18-20 in San Francisco.
-
Parse Biosciences Acquires Biomage
1/16/2024
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has acquired data analysis software company Biomage.
-
Sapio Sciences Announces Full GxP Validation Of Its Unified Lab Informatics Platform And Suite Of Solutions
1/11/2024
Sapio Sciences, the science-aware lab informatics platform, today announced that its unified platform for research and clinical informatics has been validated to comply with “good practice” quality guidelines and regulations.
-
Epredia Announces The U.S. Launch Of SlideMate Laser, Providing State-Of-The-Art Precision Slide Printing For Pathology Laboratories
1/11/2024
Epredia, a global leader in precision cancer diagnostics, today announced that it has launched U.S. sales of SlideMate Laser, the newest addition to the company’s SlideMate portfolio of slide printers, which are used in pathology laboratories to identify and help track tissue samples.
-
QPS Significantly Enhances Mass Spectrometry Laboratory Capacity
1/10/2024
QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials, and clinical research services, is rapidly expanding its mass spectrometry capacity, adding 13 LC-MS machines in just 15 months at their laboratories in Newark, Delaware (USA) and Groningen, The Netherlands (NL).
-
Mayo Clinic Platform And Techcyte Announce A Strategic Collaboration To Transform The Global Practice Of Pathology
1/8/2024
Mayo Clinic Platform, which enables global healthcare transformation through new technologies and a new approach to innovation, and Techcyte, a world leader in AI-based digital pathology, are working together to transform the global practice of pathology through the creation of a digital pathology platform.